Stephanie Lee
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fasting | 3 | 2020 | 264 | 0.950 |
Why?
| Energy Intake | 3 | 2020 | 447 | 0.870 |
Why?
| Geriatric Assessment | 1 | 2020 | 185 | 0.650 |
Why?
| Patient Compliance | 1 | 2020 | 537 | 0.550 |
Why?
| Phosphatidylinositol Phosphates | 3 | 2006 | 38 | 0.400 |
Why?
| Qc-SNARE Proteins | 1 | 2006 | 7 | 0.290 |
Why?
| Histidine | 1 | 2005 | 63 | 0.270 |
Why?
| Sulfadiazine | 1 | 2004 | 4 | 0.250 |
Why?
| Toxoplasmosis, Cerebral | 1 | 2004 | 2 | 0.250 |
Why?
| Catheters, Indwelling | 1 | 2004 | 81 | 0.250 |
Why?
| Mycobacterium Infections | 1 | 2004 | 61 | 0.240 |
Why?
| Ureteral Calculi | 1 | 2004 | 13 | 0.240 |
Why?
| Catheterization, Central Venous | 1 | 2004 | 95 | 0.230 |
Why?
| Mycobacterium | 1 | 2004 | 103 | 0.230 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 2004 | 113 | 0.230 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 348 | 0.220 |
Why?
| Mobility Limitation | 2 | 2020 | 62 | 0.220 |
Why?
| Feeding Behavior | 2 | 2019 | 601 | 0.220 |
Why?
| Bacteremia | 1 | 2004 | 161 | 0.220 |
Why?
| Pilot Projects | 3 | 2020 | 1419 | 0.200 |
Why?
| Factor Analysis, Statistical | 1 | 2020 | 270 | 0.170 |
Why?
| Membrane Proteins | 1 | 2005 | 1055 | 0.170 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2017 | 56 | 0.150 |
Why?
| Synaptosomal-Associated Protein 25 | 2 | 2006 | 26 | 0.140 |
Why?
| Interleukin-6 | 1 | 2020 | 688 | 0.140 |
Why?
| Self Report | 1 | 2020 | 699 | 0.140 |
Why?
| Body Composition | 1 | 2020 | 653 | 0.140 |
Why?
| Age Factors | 2 | 2020 | 2995 | 0.130 |
Why?
| Vesicular Transport Proteins | 2 | 2006 | 84 | 0.130 |
Why?
| Overweight | 1 | 2019 | 502 | 0.130 |
Why?
| Eating | 1 | 2017 | 369 | 0.130 |
Why?
| Weight Loss | 1 | 2019 | 655 | 0.120 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 1284 | 0.100 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2010 | 41 | 0.090 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 90 | 0.090 |
Why?
| Enterotoxigenic Escherichia coli | 1 | 2008 | 3 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2020 | 6561 | 0.080 |
Why?
| Enterotoxins | 1 | 2008 | 86 | 0.080 |
Why?
| Surveys and Questionnaires | 1 | 2020 | 4708 | 0.080 |
Why?
| Bacterial Toxins | 1 | 2008 | 106 | 0.080 |
Why?
| Escherichia coli Infections | 1 | 2008 | 105 | 0.080 |
Why?
| Travel | 1 | 2008 | 116 | 0.080 |
Why?
| Aged | 3 | 2020 | 19657 | 0.080 |
Why?
| Diarrhea | 1 | 2008 | 181 | 0.070 |
Why?
| Protein Structure, Tertiary | 2 | 2006 | 823 | 0.070 |
Why?
| Micelles | 1 | 2006 | 34 | 0.070 |
Why?
| Escherichia coli Proteins | 1 | 2008 | 170 | 0.070 |
Why?
| SNARE Proteins | 1 | 2006 | 37 | 0.070 |
Why?
| Static Electricity | 1 | 2006 | 121 | 0.070 |
Why?
| Valine | 1 | 2006 | 77 | 0.070 |
Why?
| Organothiophosphates | 1 | 2006 | 6 | 0.070 |
Why?
| Interleukin-10 | 1 | 2008 | 306 | 0.070 |
Why?
| Leucine | 1 | 2006 | 117 | 0.070 |
Why?
| Cytoplasm | 1 | 2006 | 269 | 0.070 |
Why?
| Tryptophan | 1 | 2006 | 139 | 0.070 |
Why?
| Cloning, Molecular | 1 | 2006 | 546 | 0.070 |
Why?
| Amino Acid Motifs | 1 | 2005 | 200 | 0.060 |
Why?
| Humans | 11 | 2020 | 118974 | 0.060 |
Why?
| Cytosol | 1 | 2005 | 221 | 0.060 |
Why?
| Green Fluorescent Proteins | 1 | 2006 | 395 | 0.060 |
Why?
| Endosomes | 1 | 2005 | 128 | 0.060 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2006 | 508 | 0.060 |
Why?
| Hydrogen-Ion Concentration | 1 | 2005 | 536 | 0.060 |
Why?
| Protein Transport | 1 | 2005 | 412 | 0.060 |
Why?
| HeLa Cells | 1 | 2005 | 583 | 0.060 |
Why?
| Phosphoproteins | 1 | 2005 | 308 | 0.060 |
Why?
| Transfection | 1 | 2005 | 888 | 0.060 |
Why?
| ErbB Receptors | 1 | 2006 | 569 | 0.060 |
Why?
| Lipids | 1 | 2006 | 607 | 0.050 |
Why?
| Binding Sites | 1 | 2005 | 1224 | 0.050 |
Why?
| Male | 4 | 2020 | 57801 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2005 | 551 | 0.050 |
Why?
| Stroke | 1 | 2010 | 1047 | 0.050 |
Why?
| Amino Acid Sequence | 1 | 2005 | 2071 | 0.050 |
Why?
| Female | 4 | 2020 | 61565 | 0.050 |
Why?
| Protein Binding | 1 | 2006 | 1975 | 0.050 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2008 | 2062 | 0.050 |
Why?
| Brain | 1 | 2010 | 2490 | 0.040 |
Why?
| Antigen-Antibody Reactions | 1 | 2017 | 51 | 0.040 |
Why?
| Signal-To-Noise Ratio | 1 | 2017 | 59 | 0.040 |
Why?
| Muscle Strength | 1 | 2020 | 283 | 0.040 |
Why?
| Immunoassay | 1 | 2017 | 101 | 0.040 |
Why?
| Luminescent Measurements | 1 | 2017 | 72 | 0.040 |
Why?
| Gait | 1 | 2019 | 253 | 0.040 |
Why?
| Feasibility Studies | 1 | 2019 | 749 | 0.040 |
Why?
| Recovery of Function | 1 | 2019 | 604 | 0.030 |
Why?
| Health Status | 1 | 2019 | 726 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2004 | 2436 | 0.030 |
Why?
| Adult | 3 | 2010 | 31512 | 0.020 |
Why?
| Inflammation | 1 | 2020 | 2566 | 0.020 |
Why?
| Time Factors | 1 | 2019 | 6412 | 0.020 |
Why?
| Quality of Life | 1 | 2019 | 2366 | 0.020 |
Why?
| Middle Aged | 2 | 2008 | 27617 | 0.020 |
Why?
| Mexico | 1 | 2008 | 165 | 0.020 |
Why?
| Inositol | 1 | 2006 | 26 | 0.020 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 2006 | 57 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2010 | 1795 | 0.020 |
Why?
| Organophosphorus Compounds | 1 | 2006 | 76 | 0.020 |
Why?
| Treatment Outcome | 1 | 2019 | 9342 | 0.020 |
Why?
| Molecular Structure | 1 | 2006 | 459 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 240 | 0.020 |
Why?
| Phosphorylation | 1 | 2006 | 1633 | 0.010 |
Why?
| Retrospective Studies | 1 | 2010 | 12978 | 0.010 |
Why?
| United States | 1 | 2008 | 12555 | 0.010 |
Why?
|
|
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|